Search

1. Recurrent herpes labialis: developing drugs for treatment and prevention

Publication:

Silver Spring, MD : Center for Drug Evaluation and Research, November 2017

Subject(s):

Antiviral Agents -- therapeutic use
Clinical Trials as Topic
Drug Evaluation, Preclinical
Drugs, Investigational -- therapeutic use
Herpes Labialis -- drug therapy
Herpes Labialis -- prevention & control
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration

2. Chronic hepatitis C virus infection: developing direct-acting antiviral drugs for treatment

Publication:

Silver Spring, MD : Center for Drug Evaluation and Research, November 2017

Subject(s):

Antiviral Agents -- therapeutic use
Clinical Trials as Topic
Drug Evaluation, Preclinical -- standards
Drugs, Investigational -- therapeutic use
Hepatitis C, Chronic -- drug therapy
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration

3. COVID-19 antivirals utilization: geographic and demographic patterns of treatment in 2022

Author(s):

Murphy, Stephen J. (Stephen James), author
Samson, Lok Wong, author
Sommers, Benjamin D., author

Publication:

Washington, D.C. : Department of Health and Human Services, Office of the Assistant Secretary for Planning and Evaluation, December 23, 2022

Subject(s):

Antiviral Agents -- therapeutic use
COVID-19 Drug Treatment
Drug Utilization -- statistics & numerical data
State Government
United States

4. A prototype antiviral vaccine to prevent Epstein-Barr virus-associated tumors

Publication:

[Bethesda, Md.] : National Institutes of Health, 1984

Subject(s):

Epstein-Barr Virus Infections -- prevention & control
Antiviral Agents -- therapeutic use
Vaccines